Scientists have discovered for the first time that the protein AP2A1 plays a key role in cellular aging. A study by Osaka University found that it may control the biological age of cells, opening up new possibilities in anti-aging medicine.
The researchers studied senescent cells—cells that have stopped dividing and trigger inflammatory processes. They found that AP2A1 levels were significantly higher in these cells than in young cells. When the scientists lowered AP2A1 levels, the aging cells became smaller, began dividing again and lost signs of aging. By contrast, increasing AP2A1 in young cells caused them to age prematurely.
The discovery of AP2A1 as a regulator of cellular age changes how scientists understand the aging process and raises the prospect of developing drugs that could slow or even reverse cellular aging by targeting AP2A1. However, the scientists warn that senescence is important, including for preventing cancer, so any intervention requires a cautious approach. Further research will help determine how to regulate AP2A1 levels safely to extend youth and improve health.
